1. Home
  2. Stock quotes
  3. Acasti Pharma
  4. Financial Statements
Acasti Pharma logo
Acasti Pharma ACST
$ 3.37 4.01%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Acasti Pharma Financial Statements 2011-2024 | ACST

Annual Financial Statements Acasti Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 24.5 M 20.3 M 14.8 M 55.3 M 47.2 M 13.5 M 13.6 B 16.1 M 51 M 97 M 155 M 141 M -

Shares

 44.6 M 36.8 M 14.8 M 90.7 M 54.3 M 17.5 M 10.7 B 10.7 M 10.6 M 8.44 M 7.28 M 6.72 M -

Historical Prices

 0.55 0.55 1.15 5.2 5.84 8.56 9.04 10.2 12.5 36.8 102 208 -

Net Income

 -42.4 M -9.82 M -19.7 M - -38.6 M -16.7 M - -4.66 M -1.32 M -10.4 M -6.73 M -6.54 M -2.43 M

Revenue

 - 100 M 196 K - - - - 27.8 K 216 K 450 K 707 K 127 K 29 K

Cost of Revenue

 - - 76 K - - - - - - - - - -

Gross Profit

 - - - - - - - -32.3 K 28.4 K 188 K 310 K 122 K 29 K

Operating Income

 -52.2 M -15.6 M -16.4 M -24.4 M -34.4 M - - - - - - - -

Interest Expense

 - - - - - - - - - - - - -

EBITDA

 -52 M - -16.3 M - -31 M -14 M - -5.33 M -8.04 M -8.11 M -6.17 M -5.88 M -2.42 M

Operating Expenses

 - - - 24.4 M - - - 7.06 M 9.93 M 9.89 M 7.13 M 6.67 M 2.47 M

General and Administrative Expenses

 7.61 M 9.26 M 5.52 M - 4.24 M 3.12 M - 1.61 M 4.72 M 6.03 M 4.19 M - 858 K

All numbers in USD currency

Quarterly Income Statement Acasti Pharma

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 11.5 M 10.9 M 11.5 M 7.55 M 7.44 M 7.44 M 7.44 M 7.43 M 7.39 M - 44.3 M 25.8 M 29.4 M - 12.5 M 110 M 95.1 M 90.7 M 86.8 M 83.1 M 78.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -3.43 M -2.62 M -2.39 M -3.27 M -4.02 M - -3.89 M -4.93 M -4.52 M - -3.78 M -5.92 M -3.12 M - -3.22 M -3.22 M -6.15 M -4.67 M -12.1 M -21.2 M -8.85 M -39.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 - - - - - - - - - - - - - - 81 K 81 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - 36 K 36 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -4.83 M -4.96 M -3.04 M -2.09 M -4.45 M - -4.24 M -5.11 M -4.73 M - -4.47 M -11.2 M -6.71 M - -1.96 M -1.96 M -8.03 M -4.12 M -6.15 M -6.26 M -8.01 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 - -4.96 M - - -4.45 M - -4.24 M -4.99 M -4.56 M - -4.47 M -11.2 M -6.71 M - -1.96 M -1.82 M -7.98 M -4.04 M -6.04 M -6.18 M -7.92 M 384 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 1.86 M 2.26 M 1.57 M 1.63 M 1.87 M - 1.59 M 1.68 M 1.92 M - 1.81 M 7.44 M 5.63 M - 1.1 M 1.1 M 1.32 M 1.65 M 1.58 M 1.56 M 1.12 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency